Sort
27,075 grants matching “cholesterol”
Adherence Determinants in the Health Electronic Record Evaluation of Statins (ADHERES)
$684,627Fatima Rodriguez · Stanford University · R01 · FY2025 · HL
HDL composition/function and cardiovascular risk in youths with diabetes
$684,499Tomas Vaisar · University Of Washington · R01 · FY2020 · HL
Intervention to iMProve AdherenCe equiTably (IMPACT TRIAL)
$684,388Dawn Hershman · Columbia University Health Sciences · P50 · FY2021 · MD
Optimize Risk Assessment for Incident and Recurrent Atherosclerotic Cardiovascular Disease
$684,211Yiyi Zhang · Columbia University Health Sciences · R01 · FY2023 · HL
OPtimizing Technology to Improve Medication Adherence and BP Control (OPTIMA-BP).
$684,207Carolyn Harmon Still · Case Western Reserve University · R01 · FY2023 · NR
Human CMV monoclonal antibodies as therapeutics to inhibit virus infection and dissemination
$683,927Domenico Tortorella · Icahn School Of Medicine At Mount Sinai · R56 · FY2023 · AI
Mechanisms of Advanced NAFLD Disparities in Hispanics: A Multi-level Analysis
$683,885Hugo R Rosen · University Of Southern California · R01 · FY2021 · MD
Mechanisms of Advanced NAFLD Disparities in Hispanics: A Multi-level Analysis
$683,885Veronica Wendy Setiawan · University Of Southern California · R01 · FY2022 · MD
Dynamics and mechanism of sodium-dependent carboxylate transporters
$683,853Da-Neng Wang · New York University School Of Medicine · R01 · FY2023 · DK
Reducing Clinical Inertia in Diabetes Care
$683,746Healthpartners Research Foundation · R01 · FY2005 · DK
HCC Risk Stratification in MAFLD Cirrhosis
$683,729Hashem B El-Serag · Baylor College Of Medicine · P01 · FY2023 · CA
A Neurobehavioral Family Study of Schizophrenia
$683,670Raquel E Gur · University Of Pennsylvania · R01 · FY2008 · MH
Epidemiology of Age-related Macular Degeneration and Other Retinal Diseases
$683,619Ronald Klein · University Of Wisconsin-Madison · U10 · FY2018 · EY
NEVADA ENVIRONMENTAL TOBACCO SMOKE AND HEALTH STUDY
$683,539University Of Nevada Reno · R01 · FY2001 · ES
The Impact of Omega three Fatty Acids on Vascular Function and cIMT in HIV
$683,524Christine A Wanke · Tufts University Boston · R01 · FY2013 · HL
Novel Targets for Reducing Atherosclerosis in Type 1 Diabetes
$683,486Sudha B Biddinger · Boston Children'S Hospital · R01 · FY2023 · HL
Intervention to iMProve AdherenCe equiTably (IMPACT TRIAL)
$683,321Dawn Hershman · Columbia University Health Sciences · P50 · FY2022 · MD
Northern Manhattan diabetes community health
$683,133Walter Palmas · Columbia University Health Sciences · P60 · FY2011 · MD
Effect of reproductive history on longitudinal change in cardiac, vascular and lipid parameters
$683,122Jessica G Woo · Cincinnati Childrens Hosp Med Ctr · R01 · FY2024 · HL
Low CV Risk, Ages 25-44 & CV/non-CV Outcomes, Ages 65+
$683,088Martha L Daviglus · Northwestern University At Chicago · R01 · FY2010 · HL
Evaluating Standing as a Health Behavior to Promote Cardiovascular Risk Reduction in African Americans
$682,808Keith M Diaz · Columbia University Health Sciences · R01 · FY2024 · HL
Age, Gene/Environment Susceptibility Study
$682,780Tamara Harris · National Institute On Aging · Z01 · FY2008 · AG
Health and Economic Effects of Light Rail Lines: A Natural Experiment
$682,761Stephen Paul Fortmann · Kaiser Foundation Research Institute · R01 · FY2014 · DK
Thyroid Hormone Signaling in Human Hepatocytes
$682,749Anthony N Hollenberg · Weill Medical Coll Of Cornell Univ · R01 · FY2020 · DK
Development of Oral Small Molecule PCSK9 Antagonist
$682,343Nabil A Elshourbagy · Shifa Biomedical Corporation · R44 · FY2017 · HL